0.75 / AMA PRA Category 1 CreditTM 0.75 / Nursing (NCPD) Contact Hour
Jointly provided by Haymarket Medical Education and The American Psychiatric Nurses Association
In Collaboration With
This activity is supported by an educational grant provided by Allergan.
Many clinicians may not fully appreciate the impact that the negative symptoms of schizophrenia—such as apathy, anhedonia, and social withdrawal—have on patients’ functional capacity and quality of life. Recognizing these symptoms and the burden they represent is a critical first step in treatment, as is understanding the rationale for and appropriate uses of current and emerging treatments.
Psychiatrists, primary care physicians, advanced practice registered nurses, and physician assistants who care for patients with mental health disorders in psychiatric or primary care settings
At the conclusion of this activity, participants should be better able to:
Recognize the burden of negative symptoms of schizophrenia
Identify the rationale for current and emerging treatments for bipolar depression and schizophrenia
Conflict Of Interest Disclosure Policies
In accordance with the ACCME Standards for Commercial Support, Haymarket Medical Education (HME) and the American Psychiatric Nurses Association (APNA) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME and APNA resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational activities.
Larry Culpepper, MD, MPH Professor of Family Medicine Boston University Boston, MA
Dr. Culpepper is a consultant for Acadia Pharmaceuticals, Allergan Pharmaceuticals, Eisai Pharmaceuticals, Merck & Co., Shire PLC, and Supernus Pharmaceuticals. He owns stock in M-3 Information, LLC, and has received payment from Physicians Postgraduate Press as Editor in Chief of the Primary Care Companion for CNS Diseases.
Joseph F. Goldberg, MD Clinical Professor of Psychiatry Icahn School of Medicine at Mount Sinai New York, NY
Dr. Goldberg is on the speakers’ bureaus for Allergan Pharmaceuticals, Neurocrine, Otsuka, Sunovion, and Takeda-Lundbeck. He is a consultant for Lundbeck, Neurocrine, and WebMD and receives royalties from American Psychiatric Publishing, Inc.
Accredited Provider Disclosures
Haymarket Medical Education (HME) and American Psychiatric Nurses Association (APNA) staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
HME designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Contact Hour(s)
The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity has been approved for 0.75 Nursing Continuing Education contact hour by the APNA.
Additional Credit Information
Physician Assistant Continuing Education AAPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 0.75 Category 1 Credit for completing this activity.
Disclosure of Unlabeled Use
This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Allergan, Inc., HME, or the APNA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCMETM within your Profile/CME History, which you can access at any time.